The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 03, 2022

Filed:

Jan. 06, 2017
Applicant:

Lonza Ltd, Visp, CH;

Inventors:

Colin Mark Jaques, London, GB;

Christopher Mark Smales, Canterbury, GB;

Tanya Jeane Knight, Herne Bay, GB;

Assignee:

Lonza Ltd., Visp, CH;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/50 (2006.01); C12N 5/00 (2006.01); C12N 15/65 (2006.01);
U.S. Cl.
CPC ...
G01N 33/5023 (2013.01); C12N 5/0068 (2013.01); C12N 15/65 (2013.01); G01N 33/5005 (2013.01); C12N 2501/734 (2013.01); C12N 2510/00 (2013.01);
Abstract

Disclosed herein are methods and compositions useful for evaluating, selecting, identifying, or making a cell or cell line that has improved production capacity for generating higher yields of products and/or improved capacity to produce higher quality products. Products, as described herein, can include a polypeptide that is endogenously expressed by the cell, a recombinant polypeptide that is not endogenously expressed, or a non-naturally occurring recombinant polypeptide. The methods described herein include modulating, e.g., inhibiting, the protein degradation pathway by using a proteasome inhibitor, an ER-associated degradation (ERAD) inhibitor, or a ubiquitin pathway inhibitor.


Find Patent Forward Citations

Loading…